Docetaxel 20 mg Injection bulk supplier for pharma manufacturers

Docetaxel 20 mg Injection Suppliers & Bulk Manufacturers

Available Forms: injection

Available Strengths: 20 mg/1 mL, 80 mg/4 mL,160 mg/8 mL

Reference Brands: -

Docetaxel concentrate for infusion, 20 mg/mL in 20 mg, 80 mg and 160 mg vials. A taxane cytotoxic listed for hospital pharmacies, oncology tender buyers and licensed importers who need dossier and batch documents.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Docetaxel 20 mg Injection? List it or send an offer →

Product Description:

Docetaxel is a taxane cytotoxic. It stabilises microtubules so they cannot break down, which stops dividing cells completing mitosis. This page covers concentrate for solution for infusion at 20 mg/mL, in 20 mg/1 mL, 80 mg/4 mL and 160 mg/8 mL vials. One shared concentration lets pharmacies combine vial sizes to match the calculated dose and cut waste. Single-vial concentrates have largely replaced the older two-vial presentation. The concentrate is always diluted in sodium chloride 0.9% or glucose 5% before infusion.

Docetaxel is used in breast cancer, non-small cell lung cancer, metastatic prostate cancer with prednisone or prednisolone, gastric adenocarcinoma and head and neck cancer. It is usually given as a one-hour infusion every three weeks, dosed by body surface area. An oral corticosteroid premedication limits fluid retention and hypersensitivity reactions. Neutropenia is dose-limiting, so blood counts are checked before each cycle. Liver impairment raises the risk of severe toxicity, and strong CYP3A4 inhibitors increase exposure. Most formulations contain polysorbate 80 and ethanol.

Sourcing notes. Docetaxel is on the WHO Model List of Essential Medicines. Expect a CTD or ACTD dossier with stability data for the labelled storage condition; some products are kept below 25 °C and others refrigerated, so confirm before planning transport. Cartons should protect vials from light. As a cytotoxic, it is packed, labelled and handled under hazardous-drug rules. Request a CoA per batch, the GMP certificate, a CoPP and the excipient list, including ethanol content. State vial sizes, quantity per size, shelf life at delivery and registration country.

Docetaxel 20 mg Injection — third party manufacturing & bulk supply

Docetaxel 20 mg Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Docetaxel 20 mg Injection is supplied as injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Docetaxel 20 mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Docetaxel 20 mg Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Docetaxel is used as an antineoplastic (anti-cancer) medicine to treat various types of cancers, including breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric cancer, and head and neck cancers. It works by interfering with the normal function of microtubules during cell division, thereby inhibiting the growth and spread of cancer cells.

Docetaxel injection is made from the active pharmaceutical ingredient docetaxel, a semi-synthetic taxane derived from the needles of the European yew tree (Taxus baccata). It is formulated in a solution suitable for intravenous administration, often with solubilizing agents like polysorbate 80.

Common trade names include Taxotere and Docefed.

The original brand Taxotere is manufactured by Sanofi. Generic versions are produced by multiple pharmaceutical companies worldwide.

The generic name is docetaxel.

Brand names include Taxotere and Docefed, along with various regional generics.

Docetaxel injection is manufactured in regulated pharmaceutical facilities in the USA, EU, UK, and other countries depending on the manufacturer and marketing authorization holder.